INOUE kazuyuki

J-GLOBAL         Last updated: Oct 21, 2019 at 13:17
 
Avatar
Name
INOUE kazuyuki
Affiliation
University of Shizuoka
Section
School of Pharmaceutical Sciences

Published Papers

 
Tsuji D, Ikeda M, Yamamoto K, Nakamori H, Kim Y, Kawasaki Y, Otaki A, Yokoi M, Inoue K, Hirai K, Nakamichi H, Tokou U, Shiokawa M, Itoh K.
Medicine   95 e5151   2016   [Refereed]
Hirai K, Ishii H, Shimoshikiryo T, Shimomura T, Tsuji D, Inoue K, Kadoiri T, Itoh K.
Ther Drug Monit   38(6) 706-710   2016   [Refereed]
Hirai K, Shimomura T, Moriwaki H, Ishii H, Shimoshikiryo T, Tsuji D, Inoue K, Kadoiri T, Itoh K.
Eur J Clin Pharmacol   72(10) 1177-1183   2016   [Refereed]
Inoue K, Murofushi T, Nagaoka K, Ando N, Hakamata Y, Suzuki A, Umemura A, Yoshida Y, Hirai K, Tsuji D, Itoh K.
Biol Pharm Bull   39(9) 1508-1513   2016   [Refereed]
Inoue K, Yamamoto Y, Suzuki E, Takahashi T, Umemura A, Takahashi Y, Imai K, Inoue Y, Hirai K, Tsuji D, Itoh K.
Eur J Clin Pharmacol   72(5) 555-562   2016   [Refereed]
Inoue K, Takahashi T, Yamamoto Y, Suzuki E, Takahashi Y, Imai K, Inoue Y, Hirai K, Tsuji D, Itoh K.
Seizure   33 76-80   2015   [Refereed]
Tazoe Y, Hayashi H, Tsuboi S, Shioura T, Matsuyama T, Yamada H, Hirai K, Tsuji D, Inoue K, Sugiyama T, Itoh K.
Drug Metab Pharmacokinet   30(3) 227-230   2015   [Refereed]
Hirai K, Yamada Y, Hayashi H, Tanaka M, Izumiya K, Suzuki M, Yoshizawa M, Moriwaki H, Akimoto T, Tsuji D, Inoue K, Itoh K.
Thromb Res   135(5) 861-866   2015   [Refereed]
Ikeda M, Tsuji D, Yamamoto K, Kim YI, Daimon T, Iwabe Y, Hatori M, Makuta R, Hayashi H, Inoue K, Nakamichi H, Shiokawa M, Itoh K.
Drug Metab Pharmacokinet   30(2) 149-153   2015   [Refereed]
Inoue K, Suzuki E, Takahashi T, Yamamoto Y, Yazawa R, Takahashi Y, Imai K, Miyakawa K, Inoue Y, Tsuji D, Hayashi H, Itoh K.
Epilepsy Res   108(6) 1046-1051   2014   [Refereed]
Inoue K, Suzuki E, Yazawa R, Yamamoto Y, Takahashi T, Takahashi Y, Imai K, Koyama S, Inoue Y, Tsuji D, Hayashi H, Itoh K.
Ther Drug Monit   36(3) 406-409   2014   [Refereed]
Saito M, Kondo M, Ohshima M, Deguchi K, Hayashi H, Inoue K, Tsuji D, Masuko T, Itoh K.
Cancer Sci   105(4) 396-401   2014   [Refereed]
Takahashi H, Yoshida K, Higuchi H, Kamata M, Inoue K, Suzuki T, Ishigooka J.
Neuropsychobiology   70(3) 173-180   2014   [Refereed]
Yamamoto Y, Takahashi Y, Imai K, Mishima N, Yazawa R, Inoue K, Itoh K, Kagawa Y, Inoue Y.
Epilepsia   54(6) 983-989   2013   [Refereed]
Tsuji D, Kim YI, Nakamichi H, Daimon T, Suwa K, Iwabe Y, Hayashi H, Inoue K, Yoshida M, Itoh K.
Drug Metab Pharmacokinet   28(4) 299-304   2013   [Refereed]
Tsuji D, Kamezato M, Daimon T, Taku K, Hatori M, Ikeda M, Hayashi H, Inoue K, Eto T, Itoh K.
Chemotherapy   59(6) 407-413   2013   [Refereed]
Hayashi H, Tazoe Y, Tsuboi S, Horino M, Morishita M, Arai T, Ohshima M, Matsuyama T, Kosuge K, Yamada H, Tsuji D, Inoue K, Itoh K.
Drug Metab Pharmacokinet   28(2) 164-168   2013   [Refereed]
Inoue K, Sonobe M, Kawamura Y, Etoh T, Takagi M, Matsumura T, Kikuyama M, Kimura M, Minami S, Utsuki H, Yamazaki T, Suzuki T, Tsuji D, Hayashi H, Itoh K.
Tohoku J Exp Med   229(12) 197-114   2013   [Refereed]
Yamamoto Y, Takahashi Y, Suzuki E, Mishima N, Inoue K, Itoh K, Kagawa Y, Inoue Y.
Epilepsy Res   101(3) 202-209   2012   [Refereed]
Hayashi H, Tazoe Y, Horino M, Fujimaki-Katoh C, Tsuboi S, Matsuyama T, Kosuge K, Yamada H, Tsuji D, Inoue K, Itoh K.
Drug Metab Pharmacokinet   27(2) 263-267   2012   [Refereed]
Ohshima M, Inoue K, Hayashi H, Tsuji D, Mizugaki M, Itoh K.
Protein Eng Des Sel   23(11) 881-888   2010   [Refereed]
Hayashi H, Horino M, Morishita M, Tazoe Y, Tsuboi S, Matsuyama T, Kosuge K, Yamada H, Tsuji D, Inoue K, Itoh K.
Drug Metab Pharmacokinet   25(5) 516-518   2010   [Refereed]
Ohshima M, Tadakuma T, Hayashi H, Inoue K, Itoh K.
J Biochem   147(1) 135-141   2010   [Refereed]
Miura M, Inoue K, Kagaya H, Saito M, Habuchi T, Satoh S.
Xenobiotica   39(12) 939-945   2009   [Refereed]
Yoshizawa M, Hayashi H, Tashiro Y, Sakawa S, Moriwaki H, Akimoto T, Doi O, Kimura M, Kawarasaki Y, Inoue K, Itoh K.
Thromb Res   124(2) 161-166   2009   [Refereed]
Satoh S, Saito M, Inoue T, Kagaya H, Miura M, Inoue K, Komatsuda A, Tsuchiya N, Suzuki T, Habuchi T.
Eur J Clin Pharmacol   65(5) 473-481   2009   [Refereed]
Fujiyama N, Miura M, Satoh S, Inoue K, Kagaya H, Saito M, Habuchi T, Suzuki T.
Xenobiotica   39(5) 407-414   2009   [Refereed]
Fujimaki C, Hayashi H, Tsuboi S, Matsuyama T, Kosuge K, Yamada H, Inoue K, Itoh K.
Biomarkers   14(1) 49-54   2009   [Refereed]
Itoh K, Ohshima M, Sonobe M, Saito M, Yoshida A, Hayashi H, Inoue K, Masuko T
Cancer Sci   100(1) 126-131   2009   [Refereed]
Miura M, Satoh S, Inoue K, Saito M, Habuchi T, Suzuki T.
Clin Chim Acta   399(1-2) 83-87   2009   [Refereed]
Miura M, Satoh S, Inoue K, Kagaya H, Saito M, Inoue T, Habuchi T, Suzuki T.
Steroids   73(11) 1052-1059   2008   [Refereed]
Miura M, Kagaya H, Satoh S, Inoue K, Saito M, Habuchi T, Suzuki T.
Ther Drug Monit   30(5) 559-564   2008   [Refereed]
Saito M, Satoh S, Kagaya H, Tsuruta H, Obara T, Kumazawa T, Inoue T, Inoue K, Miura M, Yuasa T, Komatsuda A, Tsuchiya N, Habuchi T.
Clin Exp Nephrol   12(4) 312-315   2008   [Refereed]
Satoh S, Kagaya H, Saito M, Inoue T, Miura M, Inoue K, Numakura K, Tsuchiya N, Tada H, Suzuki T, Habuchi T.
Br J Clin Pharmacol   66(2) 207-214   2008   [Refereed]
Kagaya H, Miura M, Satoh S, Inoue K, Saito M, Inoue T, Habuchi T, Suzuki T.
J Clin Pharm Ther   33(2) 193-201   2008   [Refereed]
Yoshida K, Higuchi H, Takahashi H, Kamata M, Sato K, Inoue K, Suzuki T, Itoh K, Ozaki N.
Hum Psychopharmacol   23(2) 121-128   2008   [Refereed]
Miura M, Satoh S, Inoue K, Kagaya H, Saito M, Suzuki T, Habuchi T.
Ther Drug Monit   30(1) 46-51   2008   [Refereed]
Miura M, Satoh S, Inoue K, Kagaya H, Saito M, Inoue T, Suzuki T, Habuchi T.
Eur J Clin Pharmacol   63(12) 1161-1169   2007   [Refereed]
Itoh K, Inoue K, Hayashi H, Suzuki T, Masuko T.
Cancer Sci   98(11) 1696-1700   2007   [Refereed]
Satoh S, Saito M, Inoue K, Miura M, Komatsuda A, Habuchi T.
Int J Urol   14(11) 990-994   2007   [Refereed]
Inoue K, Itoh K, Yoshida K, Higuchi H, Kamata M, Takahashi H, Shimizu T, Suzuki T.
Biol Pharm Bull   30(10) 1996-1998   2007   [Refereed]
Yoshida K, Higuchi H, Kamata M, Takahashi H, Inoue K, Suzuki T, Itoh K, Ozaki N.
J Psychopharmacol   21(6) 650-656   2007   [Refereed]
Inoue K, Miura M, Satoh S, Kagaya H, Saito M, Habuchi T, Suzuki T.
Ther Drug Monit   29(3) 299-304   2007   [Refereed]
Miura M, Inoue K, Kagaya H, Satoh S, Tada H, Sagae Y, Habuchi T, Suzuki T.
Biopharm Drug Dispos   28(4) 167-175   2007   [Refereed]
Hayashi H, Fujimaki C, Inoue K, Suzuki T, Itoh K.
Biol Pharm Bull   30(4) 839-841   2007   [Refereed]
Kagaya H, Inoue K, Miura M, Satoh S, Saito M, Tada H, Habuchi T, Suzuki T.
Eur J Clin Pharmacol   63(3) 279-288   2007   [Refereed]
Miura M, Inoue K, Satoh S, Itoh Y, Kagaya H, Tada H, Tanaka Y, Habuchi T, Suzuki T.
Clin Drug Investig   27(4) 251-258   2007   [Refereed]
Kagaya H, Inoue K, Miura M, Satoh S, Saito M, Tada H, Habuchi T, Suzuki T.
Yakugaku Zasshi   126(12) 1357-1362   2006   [Refereed]
Influence of ABCB1 C3435T polymorphism on the pharmacokinetics of lansoprazole and gastroesophageal symptoms in Japanese renal transplant recipients classified as CYP2C19 extensive metabolizers and treated with tacrolimus.
Miura M, Satoh S, Tada H, Saito M, Kagaya H, Inoue K, Sagae Y, Kanno S, Ishikawa M, Habuchi T, Suzuki T.
Int J Clin Pharmacol Ther   44(12) 605-613   2006   [Refereed]
Yoshida K, Takahashi H, Higuchi H, Kamata M, Ito K, Sato K, Naito S, Shimizu T, Itoh K, Inoue K, Suzuki T, Nemeroff CB.
Am J Psychiatry   161(9) 1575-1580   2004   [Refereed]
Inoue K, Itoh K, Nakao H, Takeda T, Suzuki T.
Tohoku J Exp Med   203(4) 295-303   2004   [Refereed]
Inoue K, Itoh K, Yoshida K, Shimizu T, Suzuki T.
Neuropsychobiology   50(4) 301-304   2004   [Refereed]
Itoh K, Inoue K, Tezuka T, Tada H, Hashimoto Y, Masuko T, Suzuki T.
J Biochem   133(2) 239-245   2003   [Refereed]
Yoshida K, Naito S, Takahashi H, Sato K, Ito K, Kamata M, Higuchi H, Shimizu T, Itoh K, Inoue K, Suzuki T, Ohkubo T.
Neuropsychobiology   48(1) 10-13   2003   [Refereed]
Yoshida K, Naito S, Takahashi H, Sato K, Ito K, Kamata M, Higuchi H, Shimizu T, Itoh K, Inoue K, Tezuka T, Suzuki T, Ohkubo T, Sugawara K, Otani K.
Prog Neuropsychopharmacol Biol Psychiatry   26(7-8) 1279-1283   2002   [Refereed]
Takahashi H, Yoshida K, Ito K, Sato K, Kamata M, Higuchi H, Shimizu T, Ito K, Inoue K, Tezuka T, Suzuki T, Ohkubo T, Sugawara K.
Eur Neuropsychopharmacol   12(5) 477-481   2002   [Refereed]
Ito K, Yoshida K, Sato K, Takahashi H, Kamata M, Higuchi H, Shimizu T, Itoh K, Inoue K, Tezuka T, Suzuki T, Ohkubo T, Sugawara K, Otani K.
Psychiatry Res   111(2-3) 235-239   2002   [Refereed]
Application of the CYP2C19 genotyping for estimation of the possible side-effects of drugs caused by the expected enzyme defect.
Yanagiwara S, Itoh K, Inoue K, Suzuki T.
Akita J Med   29 23-28   2002   [Refereed]
Yoshida K, Ito K, Sato K, Takahashi H, Kamata M, Higuchi H, Shimizu T, Itoh K, Inoue K, Tezuka T, Suzuki T, Ohkubo T, Sugawara K, Otani K.
Prog Neuropsychopharmacol Biol Psychiatry   26(2) 383-386   2002   [Refereed]
Tada H, Nakashima A, Awaya A, Fujisaki A, Inoue K, Kawamura K, Itoh K, Masuda H, Suzuki T.
Life Sci   70(10) 1213-1223   2002   [Refereed]
Association between -1438G/A promoter polymorphism in the 5-HT(2A) receptor gene and fluvoxamine response in Japanese patients with major depressive disorder.
Sato K, Yoshida K, Takahashi H, Ito K, Kamata M, Higuchi H, Shimizu T, Itoh K, Inoue K, Tezuka T, Suzuki T, Ohkubo T, Sugawara K, Otani K.
Neuropsychobiology   46(3) 136-140   2002   [Refereed]
Phage display cloning and characterization of monoclonal antibody genes and recombinant Fab fragment against the CD98 oncoprotein.
Itoh K, Inoue K, Hirooka K, Maruyama K, Ohkawa M, Matsui K, Tada H, Enomoto T, Hashimoto Y, Suzuki T, Masuko T.
Jpn J Cancer Res   92(12) 1313-1321   2001   [Refereed]
Itoh K, Tezuka T, Inoue K, Tada H, Suzuki T.
Tohoku J Exp Med   195(4) 237-243   2001   [Refereed]
Itoh K, Nakagomi O, Suzuki K, Inoue K, Tada H, Suzuki T.
J Biochem   125(1) 123-129   1999   [Refereed]
Itoh K, Inoue K, Yanagiwara S, Kyoya H, Suzuki T.
Biol Pharm Bull   22(1) 77-79   1999   [Refereed]
Modulation of doxorubicin resistance in a doxorubicin-resistant human leukaemia cell by an immunoliposome targeting transferring receptor.
Suzuki S, Inoue K, Hongoh A, Hashimoto Y, Yamazoe Y.
Br J Cancer   76(1) 83-89   1997   [Refereed]